SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-04-055864
Filing Date
2004-12-03
Accepted
2004-12-03 15:17:15
Documents
2
Period of Report
2004-12-01

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 3923
2 POA DOCUMENT poa.txt EX-24.3_63718 3892
  Complete submission text file 0001209191-04-055864.txt   9567
Mailing Address
Business Address 6611 TRIBUTARY ST BALTIMORE MD 21224 4106316300
GUILFORD PHARMACEUTICALS INC (Issuer) CIK: 0000918066 (see all company filings)

IRS No.: 521841960 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O BRISTOL MYERS SQUIBB CO 345 PARK AVE NEW YORK NY 10164
Business Address
MITCHELL DEAN J (Reporting) CIK: 0001199297 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-23736 | Film No.: 041183559